R&D products

LNC is working on the first gut modulator project initiated by a Medical Nutrition Product : STABLOR

Yesterday

Stablor

Medical Nutrition Product

Today

Temys Project

Gut ecosystem modulation

 logo66

We are convinced that novel therapies will revolutionize obesity management.

As a result of comprehensive action on gut modulation, they will ensure safety, efficacy
and long-term results.

+ learn more

OBESITY & MICROBIOME

In a single decades, scientific research revealed the microbiome amazing abilities on health. Gut microbiota has emerged as a driving force in the development of obesity and its metabolic disorders.

 

While current strategies to prevent overweight and obesity have demonstrated their limitations, new therapies based on the microbiota now constitute the future for the fight against obesity.

On the strength of promising results obtained on Stablor,

LNC is heading a development projet called Temys project

WHAT TEMYS Project IS ABOUT ?

Through Temys Project, LNC is developing innovative drugs
to restore intestinal ecosystem

INTESTINAL ECOSYSTEM MODULATION


Temys Project
aims to restore intestinal ecosystem by microbiome modulation, inflammation decrease and gut permeability improvement (action on mucus, epithelium and tight junctions)

PATIENT PROFILE

  • BMI > 25
  • Waist circumference
    • > 94cm for men
    • > 80cm for women
  • 2 cardiometabolic risk factors

Discover Stablor, the first microbiome modulator against obesity

STABLOR
Medical Nutrition Product
Publications

In order to be on the cutting edge of scientific research and innovation, we select and analyse key scientific publications and materials

Discover our selection

Find out more
The strong protective role of...
Variation in the human fecal microbiota has previously been associated with body mass index (BMI)....
C.minuta is the species related...
Host genetics and the gut microbiome can both influence metabolic phenotypes. Here, Goodrich et al....
What is the link between...
Evidence suggests the gut microbiome is involved in the development of cardiovascular disease (CVD),...